Basics of Vaccines PDF Print E-mail
basicsWhat is a vaccine?
A vaccine is a medical product designed to stimulate your body's immune system in order to prevent or control an infection. An effective preventive vaccine trains your immune system to fight off a particular microorganism so that it can't establish a serious infection or make you sick.

What is the difference between a preventive HIV vaccine and a therapeutic HIV vaccine?
Therapeutic HIV vaccines are designed to control HIV infection in people who are already HIV positive (see Therapeutic HIV Vaccines Fact Sheet). Preventive HIV vaccines are designed to protect HIV negative people from becoming infected or getting sick. This fact sheet focuses on preventive HIV vaccines.

Although there is currently no vaccine to prevent HIV, researchers are developing and testing potential HIV vaccines. The goal is to develop a vaccine that can protect people from HIV infection, or at least lessen the chance of getting HIV or AIDS should a person be exposed to the virus.


Preventive Vaccine

How does a preventive vaccine work?
When your body encounters a microorganism, your immune system mounts an attack on the invader. After the microorganism is defeated, your immune system continues to "remember" how to quickly beat the invader should it try to infect you again.

A vaccine is designed to resemble a real microorganism.

The vaccine trains your immune system to recognize and attack the real microorganism should you ever encounter it. If you've received an effective vaccine, your immune system will "remember" how to quickly attack and defeat a particular microorganism for many years.

Can an HIV vaccine give me HIV or AIDS?
The experimental HIV vaccines currently being studied in clinical trials do not contain any "real" HIV, and therefore cannot cause HIV or AIDS. However, some HIV vaccines in trials could prompt your body to produce antibodies against HIV. These HIV antibodies could cause you to test "positive" on a standard HIV test, even if you don't actually have HIV. Other tests are available that can distinguish between vaccinated and infected people.

What are the different types of vaccine?
There are three main types of vaccines that are being studied for the prevention of HIV infection and AIDS:

  • Subunit vaccines, also known as "component" or "protein" vaccines, contain only individual parts of HIV, rather than the whole virus. Instead of collecting these parts from the virus itself, the HIV subunits are made in the laboratory using genetic engineering techniques. These man-made subunits alone—without the rest of the virus—can prompt the body to produce an anti-HIV immune response, although that response may be too weak to actually protect against future HIV infection. 
  • Recombinant vector vaccines take advantage of non-HIV viruses that either don't cause disease in humans or have been deliberately weakened so that they can't cause disease. These weakened (attenuated) viruses are used as vectors, or carriers, to deliver copies of HIV genes into the cells of the body. Once inside cells, the body uses the instructions carried in the copies of HIV genes to produce HIV proteins. As with subunit vaccines, these HIV proteins can stimulate an anti-HIV immune response. Most of the recombinant vector vaccines for HIV deliver several HIV genes (but not the complete set) and may therefore create a stronger immune response.

Some of the virus vectors being studied for HIV vaccines include ALVAC (a canarypox virus), MVA (a type of cowpox virus), VEE (a virus that normally infects horses), and adenovirus-5 (a human virus that doesn't usually cause serious disease) based vectors.

  • DNA vaccines also introduce HIV genes into the body. Unlike recombinant vector vaccines, DNA vaccines do not rely on a virus vector. Instead, "naked" DNA containing HIV genes is injected directly into the body. Cells take up this DNA and use it to produce HIV proteins. As with subunit and recombinant vector vaccines, the HIV proteins trigger the body to produce an immune response against HIV.

Again, none of these vaccines contain real HIV or anything else that could cause HIV infection or AIDS.

What is a prime-boost vaccination strategy?

A single type of HIV vaccine may be used alone, or it may be used in combination with another type of HIV vaccine. One approach to combined HIV vaccination is called the prime-boost strategy. In this approach, administration of one type of HIV vaccine (such as a DNA vaccine) is followed by later administration of a second type of HIV vaccine (such as a recombinant vector vaccine). The goal of this approach is to stimulate different parts of the immune system and enhance the body's overall immune response to HIV.

How can I participate in a vaccine clinical trial?
Clinical trial volunteers are tremendously important in the effort to develop a preventive HIV vaccine.
Enrolling in a clinical trial isn’t the only way to help the HIV vaccine effort—there are other ways to participate. Consider serving on an HIV vaccine Community Advisory Board. Get involved with outreach and community education programs. Lobby your elected officials to support HIV vaccine research and development. Or volunteer in other HIV/AIDS prevention, treatment, and support efforts—all are valuable ways to contribute.

Therapeutic Vaccine

What is a therapeutic HIV vaccine?
A therapeutic HIV vaccine (also known as a treatment vaccine) is a vaccine used in the treatment of an HIV infected person. Therapeutic HIV vaccines are designed to boost the body's immune response to HIV in order to better control the infection.

Currently, there are no therapeutic HIV vaccines approved by the Food and Drug Administration (FDA). However, therapeutic HIV vaccines are being tested in clinical trials to find out if they are safe and effective in treating people with HIV.

Researchers hope that if therapeutic vaccines are able to strengthen the body's natural anti-HIV immune response, people with HIV will not have to rely exclusively on the antiretroviral drugs now used to treat HIV infection. Currently, antiretroviral drugs must be taken for life, and some cause serious side effects.

All experimental therapeutic HIV vaccines are in very early stages of research, and no therapeutic vaccine is anticipated to be available to the general public for many years, if at all.

Will a therapeutic HIV vaccine be able to cure HIV?

Probably not. If therapeutic vaccines are effective, they may be able to help keep HIV infection under control. However, most researchers do not think therapeutic HIV vaccines will be able to completely eliminate HIV infection, because the virus hides in certain cells of the body where it can last for decades.

Will a therapeutic vaccine rule out the need for antiretroviral drugs?
Even an effective therapeutic HIV vaccine probably won't be able to replace antiretroviral drugs entirely. At best, a therapeutic HIV vaccine may help control HIV infection and keep people healthy while minimizing the need for antiretroviral drugs.

Who is eligible to receive a therapeutic vaccine?
Therapeutic vaccines are designed specifically for HIV positive people who have healthy immune systems. Therapeutic vaccine recipients must have strong immune systems for the vaccine to generate an effective anti- HIV immune response. Clinical trials of therapeutic vaccines are recruiting volunteers with CD4 counts greater than 250 cells/mm3, and most studies require a CD4 count greater than 350 cells/mm3. People with weaker immune systems may be unable to produce a good immune response to a therapeutic HIV vaccine, and are therefore not eligible for these trials. Most trials require that therapeutic vaccine recipients continue taking antiretroviral drugs during the study.

What are the side effects of therapeutic vaccines?
Because testing is ongoing, not all of the side effects of therapeutic vaccines are known. However, side effects observed so far in clinical trials have been similar to the side effects that occur with FDA-approved vaccines. These side effects include:

  • Soreness, swelling, redness, or pain at the site of injection
  • Mild flu-like symptoms (fever, chills, muscle pain or weakness, nausea, headache, and dizziness)